223611-40-3

Basic information

• Product Name: 1,1,1-triphenyl-2,5,8,11-tetraoxatridecan-13-yl 4-methylbenzenesulfonate
• Synonyms: 1,1,1-triphenyl-2,5,8,11-tetraoxatridecan-13-yl 4-methylbenzenesulfonate
• CAS NO: 223611-40-3
• Molecular Weight: 590.738
• Mol File: 223611-40-3.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 1,1,1-triphenyl-2,5,8,11-tetraoxatridecan-13-yl 4-methylbenzenesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 1,1,1-triphenyl-2,5,8,11-tetraoxatridecan-13-yl 4-methylbenzenesulfonate(223611-40-3)
• EPA Substance Registry System: 1,1,1-triphenyl-2,5,8,11-tetraoxatridecan-13-yl 4-methylbenzenesulfonate(223611-40-3)

Safety Data

• Hazardous Substances Data: 223611-40-3(Hazardous Substances Data)

Upstream product

• 76-83-5 trityl chloride 
• 77544-60-6 p-toluenesulfonic acid 2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl ester 
• 125274-16-0 1,1,1-triphenyl-2,5,8,11-tetraoxatridecan-13-ol 
• 98-59-9 p-toluenesulfonyl chloride 
• 112-60-7 Tetraethylene glycol 

Downstream Products

• 477775-73-8 1-phenyl-2,5,8,11,14,17,20,23-octaoxapenta-cosan-25-ol 
• 1351556-81-4 2-(2-{2-[2-(2-{2-[2-(2-prop-2-ynyloxyethoxy)ethoxy]ethoxy}ethoxy)ethoxy]ethoxy}ethoxy)ethanol 
• 1036204-61-1 C₂₇H₅₂O₁₃ 
• 1351556-80-3 1,1,1-triphenyl-2,5,8,11,14,17,20,23,26-nonaoxanonacos-28-yne 
• 1585235-92-2 63-(4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)phenyl)-1,1,1-triphenyl-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62-henicosaoxatrihexacontane 
• 1585235-90-0 51-(4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)phenyl)-1,1,1-triphenyl-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-heptadecaoxahenpentacontane 
• 1585235-88-6 9-(4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)phenyl)-1,1,1-triphenyl-2,5,8,11,14,17,20,23,26,29,32,35,38-tridecaoxanonatriacontane 
• 1585235-86-4 27-(4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)phenyl)-1,1,1-triphenyl-2,5,8,11,14,17,20,23,26-nonaoxaheptacosane 
• 1201411-02-0 C₃₂H₃₆N₆O₄ 
• 1107609-32-4 tetraethylene glycol trityl-6-cyano-2-naphthyl ether 
• 223611-36-7 thioacetic acid S-[2-(2-{2-[2-(2-{2-[2-(2-trityloxy-ethoxy)-ethoxy]-ethoxy}-ethylsulfanyl)-ethoxy]-ethoxy}-ethoxy)-ethyl] ester 
• 223611-44-7 methanesulfonic acid 2-(2-{2-[2-(2-{2-[2-(2-trityloxy-ethoxy)-ethoxy]-ethoxy}-ethylsulfanyl)-ethoxy]-ethoxy}-ethoxy)-ethyl ester 
• 223611-43-6 2-(2-{2-[2-(2-{2-[2-(2-trityloxy-ethoxy)-ethoxy]-ethoxy}-ethylsulfanyl)-ethoxy]-ethoxy}-ethoxy)-ethanol 
• 223611-42-5 S-(2-{2-[2-(2-hydroxyethoxy)ethoxy]ethoxy}ethyl)thioacetate 

Relevant articles and documents

INHIBITORS OF CYCLIN-DEPENDENT KINASES AND USES THEREOF

Provided are novel compounds of Formula (I); pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by CDK such as cancer.

SUPRAMOLECULAR PROTEIN ASSEMBLIES WITH ADVANCED FUNCTIONS AND SYNTHESIS THEREOF

The present invention discloses stimuli-sensitive protein conjugate which can make supramolecular protein assemblies and methods for using the same. The present invention provides simple and rational process for construction of said stimuli-sensitive spherical protein assemblies through supramolecular chemical strategy.

Synthesis of gemini surfactants with twelve symmetric fluorine atoms and one singlet 19F MR signal as novel 19F MRI agents

A family of fluorinated gemini surfactants derived from perfluoropinacol has been synthesized as novel 19F magnetic resonance imaging ( 19F MRI) agents. These fluorinated surfactants with 12 symmetric fluorine atoms and one singlet